Skip to main content
. 2021 Jun 18;39(2):113–121. doi: 10.3857/roj.2021.00213

Fig. 3.

Fig. 3.

(A) Kaplan-Meier curve for all patients. Median overall survival (OS) was 14 months. (B) Kaplan-Meier curve comparing 90Y-SBRT responders (CR+PR+SD) versus non-responders (PD). Median OS for responders was 33 months versus 2 months for non-responders (p < 0.001). SBRT, stereotactic body radiation therapy; 90Y, yttrium-90; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.